Yu Guanglin, Hubel Allison
Department of Mechanical Engineering, University of Minnesota, Minneapolis, MN, USA.
Regen Eng Transl Med. 2019;5(4):323-331. doi: 10.1007/s40883-019-00110-9. Epub 2019 May 31.
Regenerative medicine (RM) has the potential to restore or establish normal function of cells, tissues and organs that have been lost due to age, disease or injury. It is common for the site of raw material collection, site of manufacture and site of clinical use to be different for RM products, and at the same time cells must remain viable and functional during transportation among different sites. Freezing products down to cryogenic temperatures along with cold chain transportation has become an effective method of preserving RM products. The quality of RM products along this supply chain represents the cumulative effects of all of the processing steps and all of the reagents used in the process. A variety of sources of variability in the preservation of RM products can result in both cell losses and greater variability in the quality of RM products. The purpose of this article is to review the sources of variability in the preservation process as well as the methods by which variability can be controlled or avoided.
再生医学(RM)有潜力恢复或重建因年龄、疾病或损伤而丧失的细胞、组织和器官的正常功能。RM产品的原材料采集地、生产地和临床使用地通常不同,同时,细胞在不同地点之间运输过程中必须保持存活和功能正常。将产品冷冻至低温并进行冷链运输已成为保存RM产品的有效方法。这条供应链上RM产品的质量代表了所有加工步骤以及该过程中使用的所有试剂的累积效应。RM产品保存过程中存在多种变异性来源,可能导致细胞损失以及RM产品质量出现更大的变异性。本文旨在综述保存过程中的变异性来源以及控制或避免变异性的方法。